Using Research-Ready Data to Accelerate Clinical Research

At LexisNexis® Risk Solutions, we drive healthcare innovation by providing life sciences companies and clinical research organizations (CROs) with valuable, research-ready data to empower organizations and research teams to advance and accelerate healthcare innovation.  Our advanced, secure and certified datasets that have been de-identified by our proprietary tokenization technology can help clinical researchers and their teams be more strategic in decision making, support improved patient outcomes and optimize new and novel therapies.  Using our precisely linked data, we can help clinical research teams:

• Enable continuous monitoring for superior research outcomes and more effective healthcare delivery
• Reduce time-to-market 
• Enhance precision medicine

Our solutions drive better research efficacy through secure, high-quality data that helps to ensure more informed decisions, cost savings and a reduced time to the implementation of treatments and therapies.  

Here’s how our solutions address key challenges in clinical research:

Speed to Market: Faster Trials for New Therapies and Label Expansions

LexisNexis® Risk Solutions accelerates clinical trial design by providing deep insights into patient demographics, treatment histories and comorbidities. Researchers can identify relevant patient cohorts, predict drug performance and reduce clinical trial costs & timelines. These enhanced capabilities help bring new therapies to market faster and support expanded indications with greater efficiency.

Post-Market Surveillance and Pharmacovigilance: Safer Drugs and Healthier Patients

Our platform integrates clinical, claims and social determinants of health (SDOH) data, to enable comprehensive monitoring of drug safety and effectiveness. This robust data integration helps: 

• Identify adverse events and long-term risks that may not have been detected during clinical trials
• Ensures continuous patient safety 
• Improves pharmacovigilance efforts

Optimizing HEOR and Cost-Effectiveness Modeling for Smarter Resource Allocation

LexisNexis® Risk Solutions combines clinical outcomes with claims and SDOH data to enhance health economics and outcomes research (HEOR). This powerful data integration supports more informed reimbursement decisions and more accurate cost-effectiveness assessments, helping stakeholders make data-driven choices that optimize healthcare resource allocation.

Robust Data Integrations that Advance Precision Medicine and Health Equity

By integrating clinical, genomic and socio-economic data, we help researchers identify patient subgroups that may benefit from personalized treatments based on social factors. This holistic approach improves outcomes in critical therapeutic areas such as oncology, cardiology and diabetes, advancing precision medicine and health equity.

Informed Decisions with Real-World Evidence (RWE) and Health Outcomes Modeling

Our solutions generate RWE by combining diverse datasets which can be used to evaluate treatment effectiveness and safety across patient populations. We empower researchers to drive informed drug development, treatment guidelines and healthcare management strategies, to ensure better healthcare outcomes and evidence-based decision-making.

Download our whitepaper to learn how LexisNexis® Risk Solutions can transform your clinical research with secure, enriched data and integrated technology solutions. Accelerate innovation, enhance patient outcomes and support compliance across the dynamic healthcare landscape.